Psychiatry 70 KroenkeK.WuJ.BairM
Efficacy and safety of GLP-1 receptor agonists as add-on to SGLT2 inhibitors in type 2 diabetes mellitus: A meta-analysis
At 90.6% (95% CI, 89.5%-91.6%) unweighted and 99.9% (95% CI, 94.6%-105.3%) weighted, tirzepatide had the most patients meet the FDA label eligibility criteria for weight loss treatment, followed by semaglutide at 89.0%(95% CI, 87.9%-90.1%) and 98.2% (95% CI, 92.8%-103.6%), respectively, and liraglutide at 88.9% (95% CI, 87.8%-90.0%) and 98.1% (95% CI, 92.7%-103.5%)
Can I get GLP-1s for free
GLPOne Weight Loss (Glendale) Get to Know GLPOne Weight Loss (Glendale) GLP One Weight Loss offers individualized weight-loss care centered around GLP1 medications